Xtx Topco LTD Eagle Pharmaceuticals, Inc. Transaction History
Xtx Topco LTD
- $1.13 Billion
- Q4 2024
A detailed history of Xtx Topco LTD transactions in Eagle Pharmaceuticals, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 23,594 shares of EGRX stock, worth $27,604. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,594
Previous 22,437
5.16%
Holding current value
$27,604
Previous $83,000
86.75%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding EGRX
# of Institutions
30Shares Held
3.82MCall Options Held
1MPut Options Held
100-
Black Rock Inc. New York, NY353KShares$412,7310.0% of portfolio
-
Ajo Vista, LLC Boston, MA56.4KShares$66,0320.92% of portfolio
-
Simplex Trading, LLC18.2KShares$21,2490.0% of portfolio
-
Barclays PLC London, X014.2KShares$16,6520.0% of portfolio
-
Stanley Laman Group, Ltd. Berwyn, PA12KShares$14,0400.0% of portfolio
About EAGLE PHARMACEUTICALS, INC.
- Ticker EGRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 13,015,900
- Market Cap $15.2M
- Description
- Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...